EyePoint Pharmaceuticals (EYPT) Change in Acquisitions & Divestments: 2010-2017
Historic Change in Acquisitions & Divestments for EyePoint Pharmaceuticals (EYPT) over the last 3 years, with Jun 2017 value amounting to $2.5 million.
- EyePoint Pharmaceuticals' Change in Acquisitions & Divestments was N/A to $2.5 million in Q2 2017 from the same period last year, while for Jun 2017 it was $18.7 million, marking a year-over-year change of. This contributed to the annual value of $183.0 million for FY2024, which is 231.02% up from last year.
- Per EyePoint Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $2.5 million for Q2 2017, which was down 25.37% from $3.4 million recorded in Q1 2017.
- EyePoint Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $7.5 million during Q3 2016, with a 5-year trough of $500,000 in Q1 2014.
- Over the past 2 years, EyePoint Pharmaceuticals' median Change in Acquisitions & Divestments value was $4.4 million (recorded in 2016), while the average stood at $4.7 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 121.01% in 2013 and then plummeted by 86.65% in 2014.
- Quarterly analysis of 4 years shows EyePoint Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.4 million in 2013, then plummeted by 86.65% to $500,000 in 2014, then reached $5.4 million in 2016, then reached $2.5 million in 2017.
- Its last three reported values are $2.5 million in Q2 2017, $3.4 million for Q1 2017, and $5.4 million during Q4 2016.